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Abstract: Sialyltransferases transfer N-acetylneuraminic acid (Neu5Ac) from the common 
donor  substrate  of  these  enzymes,  cytidine  5’-monophospho-N-acetylneuraminic  acid 
(CMP-Neu5Ac),  to  acceptor  substrates.  The  enzymatic  reaction  products  including 
sialyl-glycoproteins, sialyl-glycolipids and sialyl-oligosaccharides are important molecules 
in  various  biological  and  physiological  processes,  such  as  cell-cell  recognition,  cancer 
metastasis,  and  virus  infection.  Thus,  sialyltransferases  are  thought  to  be  important 
enzymes  in  the  field  of  glycobiology.  To  date,  many  sialyltransferases  and  the  genes 
encoding them have been obtained from various sources including mammalian, bacterial 
and viral sources. During the course of our research, we have detected over 20 bacteria that 
produce sialyltransferases. Many of the bacteria we isolated from marine environments are 
classified  in  the  genus  Photobacterium  or  the  closely  related  genus  Vibrio.  The  paper 
reviews the sialyltransferases obtained mainly from marine bacteria.  
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1. Introduction 
Sialic acids are important components of carbohydrate chains and are usually found on the terminal 
position of the carbohydrate moiety of glycoconjugates, including glycoproteins and glycolipids [1,2]. 
Many studies have shown that the sialyloligosaccharides of glycoconjugates play significant roles in 
many biological processes, such as inflammatory and immunological responses, cell–cell recognition, 
cancer metastasis and viral infection [3–7]. The transferring of sialic acids to carbohydrate chains is 
performed  by  specific  sialyltransferases  in  the  cell  [2,8].  Therefore,  the  sialyltransferases  are 
considered to be key enzymes in the biosynthesis of sialylated glycoconjugates. Detailed investigations 
of  the  biological  functions  of  sialylated-glycoconjugates  require  an  abundant  supply  of  the  target 
compounds. Chemical and enzymatic glycosylation have been the two major routes for the preparation 
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of sialylated-glycoconjugates. Although chemical glycosylation has the advantage of high flexibility 
and wide applicability, the reaction processes are complicated as the chemical reactions often require 
multiple protection and de-protection steps [9–11]. On the other hand, enzymatic glycosylation using 
glycosyltransferases  is  a  single-step  process  with  high  positional  and  anomer  selectivity  and  high 
reaction  yield.  For  example,  in  sialylation,  the  transfer  of  Neu5Ac  by  sialyltransferases  from 
CMP-Neu5Ac to the appropriate substrate can be readily achieved under mild reaction conditions [12]. 
Generally, bacterial enzymes are more stable and productive in Escherichia coli protein expression 
systems  than  the  mammalian-derived  enzymes,  and  mammalian  enzymes  have  stricter  acceptor 
specificity. Therefore, we have screened many marine bacteria for novel sialyltransferase activity to 
enzymatically produce sialylated glycoconjugates and sialyloligosaccharides in large amounts. During 
the course of our research, we have identified over 20 bacteria that produce sialyltransferases, many of 
which are classified in the genus Photobacterium or the closely related genus Vibrio [13]. Furthermore, 
we  have  also  revealed  that  the  bacteria-derived  sialyltransferases  show  broader  acceptor  substrate 
specificity than the mammalian enzymes [13]. These advantages highlight the capacity of bacterial 
enzymes  to  serve  as  efficient  tools  for  the  in vitro  enzymatic  modification  or/and  synthesis  of 
sialylated-glycoconjugates and sialyloligosaccharides [13]. 
2. Sialic Acid 
2.1. Structure and distribution 
Sialic  acids  (Sias)  are  a  family  of  monosaccharides  comprising  over  50  naturally  occurring 
derivatives  of  neuraminic  acid,  5-amino-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic  acid 
(Neu) [1,2]. Structurally, the Sia derivatives of Neu carry a variety of substitutions at the amino and/or 
hydroxyl groups. The amino acid group is often acetylated, glycolylated, or replaced by a hydroxyl 
group. The hydroxyl groups can be acetylated at O4, O7, O8, or O9, singly or in combination [2], and 
can also be modified by acetate, lactate, phosphate or sulfate esters. 
The  three  major  members  of  the  Sia  group  are  N-acetylneuraminic  acid  (Neu5Ac), 
N-glycolylneuraminic  acid  (Neu5Gc),  and  2-keto-3-deoxy-D-glycero-D-galacto-nonulosonic  acid 
(KDN) [1,2]. Although, Sias are widely distributed in higher animals and some microorganisms, only 
Neu5Ac is ubiquitous, and Neu5Gc is not found in bacteria [2]. Usually, Sias exist in the carbohydrate 
moiety of glycoconjugates, and are linked to the terminal positions of the carbohydrate chains of the 
glycoconjugates [2]. The structures of three major sialic acids are described in Figure 1.  
Figure 1. Structures of major three sialic acids. (A) N-acetylneuraminic acid (Neu5Ac); 
(B) N-glycolylneuraminic acid (Neu5Gc); (C) 2-keto-3-deoxy-D-glycero-D-galacto-noninic 
acid (KDN). 
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2.2. Importance of sialyloligosaccharides 
In  the  sialylated  glycoconjugates,  mainly  four  linkage  patterns,  including  Neu5Ac2-6Gal, 
Neu5Ac2-3Gal, Neu5Ac2-6GalNAc, and Neu5Ac2-8Neu5Ac, are found [1,2]. These structures 
are formed by specific sialyltransferases in the cell. As described above, sialyloligosaccharides of 
glycoconjugates  play  important  roles  in  many  biological  processes.  For  example,  the  relationship 
between the structure of carbohydrate chains and the recognition of the host cell by influenza virus is 
one of the best understood biological phenomena. Many studies have shown that influenza A and B 
viruses bind to cell surface receptors of host cells via Neu5Ac-linked glycoproteins or glycolipids 
through viral hemagglutinin recognition of host cell Neu5Ac [14–16]. Furthermore, it has been clearly 
demonstrated that these influenza viruses also recognize the carbohydrate chain structure of the host 
cell [15]. For example, the avian influenza viruses recognize Neu5Ac2-3Gal1-3/4GlcNAc structures, 
and the human influenza viruses recognize Neu5Ac2-6Gal1-3/4GlcNAc structures [14,15]. The host 
cell  specificity  of  the  influenza  viruses  is  determined  mainly  by  the  linkage  of  Neu5Ac  to  the 
penultimate galactose residues and core structures. Thus, the distribution of Neu5Ac and its linkage 
patterns on the host cell surface are important determinants of host tropism [17,18]. 
3. Sialyltransferase 
3.1. Classes and sources sialyltransferases 
To date, many sialyltransferases have been obtained from mammals, bacteria and viruses [8,19,20]. 
They  are  classified  into  four  families  according  to  the  carbohydrate  linkages  they  synthesize:  the 
beta-galactoside  2,3-sialyltransferases  (ST3Gal  I–VI),  the  beta-galactoside  2,6-sialyltransferases 
(ST6Gal I, II), the GalNAc 2,6-sialyltransferases (ST6GalNAc I–VI), and the 2,8-sialyltransferases 
(ST8Sia I–VI) [8]. On the other hand, all the sialyltransferases have been also classified into five 
families on the basis of sequence similarities in the CAZy (carbohydrate-active enzymes) database [21], 
i.e.,  glycosyltransferase  family  (GT)  29,  various  sialyltransferases  from  eukaryotes  and  viruses; 
family 38, polysialyltransferase from bacteria such as Escherichia coli; family 42, lipooligosaccharide 
2,3-sialyltransferase from bacteria such as Campylobacter jejuni; family 52, 2,3-sialyltransferase 
from  bacteria  such  as  Neisseria  gonorrhoeae;  and  family  80,  2,6-sialyltransferase  from  marine 
bacteria such as Photobacterium damselae.  
It  has  been  revealed  that  mammalian  sialyltransferases  contain  conserved  sequence  motifs, 
including  sialyl  motifs  L,  S,  VS  and  motif  III  [22–24].  Very  recently,  a  crystal  structure  of  the 
mammalian sialyltransferase was reported [25]. Some functions of these motifs have been clarified. 
For  example,  mutagenesis  studies  have  demonstrated  that  motif  L  is  involved  in  donor  substrate 
binding  [26] and that  motif  S is  involved in  donor and acceptor substrate binding  [22].  Like the 
mammalian  sialyltransferases,  viral  2,3-sialyltransferase,  obtained  from  myxoma-virus-infected 
RK13 cells, contains the motifs L and S in its catalytic domain and is closely related to mammalian 
2,3-sialyltransferase (ST3Gal IV) on the basis of amino acid sequence similarity [20]. The substrate 
specificity  of  the  viral  and  mammalian  sialyltransferases  is  very  different,  despite  the  common 
presence of the sialyl motifs.  Mar. Drugs 2010, 8  
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The  known  bacterial  sialyltransferases  do  not  contain  the  sialyl  motifs  found  in  mammalian 
sialyltransferases [19,20]. Two short motifs, referred to as the D/E-D/E-G and HP motifs, have been 
recently identified in the bacterial sialyltransferases and are shown to be functionally important for 
enzyme catalysis and donor substrate binding [27]. These two motifs are structurally distinct from the 
motifs found in mammalian sialyltransferases. Furthermore, it has been also demonstrated that the 
three conserved functional motifs, named YDDGS motif, FKGHP motif and SS motif, exist in the 
bacterial sialyltransferases that have been classified into GT family 80 [28]. 
3.2. Classification of sialyltransferases produced by bacteria 
Genes  encoding  sialyltransferases  have  been  cloned  from  various  types  of  bacteria,  including 
N. gonorrhoeae  [29],  Neisseria  meningitidis  [30],  C.  jejuni  [31],  E.  coli  [32],  P.  damselae  [33], 
Photobacterium  phosphoreum  [34],  Photobacterium  leiognathi  [35,36],  Photobacterium  sp.  [37], 
Vibrio  sp.  [38],  Pasteurella  multocida  [39],  Haemophilus  influenzae  [40],  and 
Streptococcus agalactiae [41]. As described above, all bacterial sialyltransferases are classified into 
four families in the CAZy database: (1) glycosyltransferase (GT) family 38 (polysialyltransferase from 
E.  coli  and  N.  meningitidis);  (2)  GT  family  42  (lipooligosaccharide  2,3-sialyltransferase  and  
2,3-/2,8-sialyltransferase from C. jejuni and H. influenzae); (3) GT family 52 (2,3-sialyltransferase 
from H. influenzae, N. gonorrhoeae, and N. meningitidis); and (4) GT family 80 (2,6-sialyltransferase 
and  2,3-/2,6-sialyltransferase  from  P.  damselae  and  P.  multocida).  Some  marine  bacterial 
sialyltransferases  also  show  both  sialyltransferase  and  neuraminidase  activities.  The  relationship 
between the marine bacterial sialyltransferases and type of enzyme activities is listed in Table 1.  
Table 1. The relationship between marine bacteria and enzyme activities. 
Enzyme origin 
Enzyme activities 
Sialyltransferase activity  Neuraminidase activity 
Photobacterium phosphoreum JT-ISH-467 
2,3-sialyltransferase 
+ 
Photobacterium sp. JT-ISH-224  + 
Vibrio sp. JT-FAJ-16  − 
Photobacterium damselae JT0160 
2,6-sialyltransferase 
− 
Photobacterium leiognathi JT-SHIZ-119  + 
Photobacterium leiognathi JT-SHIZ-145  − 
Photobacterium sp. JT-ISH-224  − 
Recently, it has been also reported that marine bacteria producing 2,6-sialyltransferases express 
Neu5Ac residue on their cell surfaces [42].  Among the bacteria producing  2,6-sialyltransferases, 
P. damselae is known as a causative agent of wound infection, ulceration and pasteurellosis [43–45]. 
As  described  in  the  introduction,  sialyloligosaccharides  are  important  molecules  for  cell–cell 
interaction  and  infection.  Although  the  structures  of  the  sialyloligosaccharides  produced  by  the 
bacteria are still unknown, the molecules  containing Neu5Ac on their cell surfaces  that might be 
produced by the enzymes may be involved in virulence and adhesion to host cells.  Mar. Drugs 2010, 8  
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4. Enzymatic Properties of Marine Bacterial Sialyltransferases 
4.1. An 2,6-sialyltransferase produced by P. damselae JT0160 
To date, it has been demonstrated that the 2,6-sialyltransferase produced by P. damselae JT0160 
has unique acceptor substrate specificity compared with the mammalian counterparts. First, it has been 
revealed  that  P.  damselae  2,6-sialyltransferase  transfers  Neu5Ac  to  both  glycoproteins  including 
asialo-N-linked  and  asialo-O-linked  glycoproteins  and  glycolipids  [46,47].  However,  rat  liver  
2,6-sialyltransferase  has  a  Km  value  approximately  33-times  higher  for  lactose  than  for 
N-acetyllactosaminide, P. damselae 2,6-sialyltransferase recognizes lactose and N-acetyllactosaminide 
as  acceptor  substrates  with  almost  equal  Km  values  [48].  These  result  indicates  that  P.  damselae 
2,6-sialyltransferase does not recognize the 2-acetamido group in the N-acetylglucosaminyl residue, 
unlike the mammalian enzymes. The acceptor substrate specificity of mammalian sialyltransferases is 
generally high, and mammalian enzymes are specific for the type of the sugars and linkages. For 
example,  mammalian  sialyltransferases  do  not  recognize  fucosylated  carbohydrate  chains  as  an 
acceptor substrate. In eukaryotes, the carbohydrate chain moieties of glycoconjugate are synthesized 
by  a series  of  glycosyltransferases, and the order of  glycosylation  is  determined strictly. Usually, 
fucosylation is performed by fucosyltransferases after sialylation in mammalian cell. Thus, mammalian 
sialyltransferases do not recognize fucosylated carbohydrate chain as acceptor substrates and cannot 
transfer Neu5Ac to them. However, P. damselae 2,6-sialyltransferase does recognizes fucosylated 
carbohydrate  chains  as  an  acceptor  substrate  and  transfers  Neu5Ac  to  the  galactose  residue  of 
carbohydrate chains at position 6 in 2’-fucosyllactose [49]. In addition, the 2,6-sialyltransferase also 
recognizes 3’-sialyllactose and gives 3’,6’-disialyllactose as the reaction product [49]. The structures 
of the reaction products derived from 2’-fucosyllactose and 3’-sialyllactose are described in Figure 2.  
Figure 2. Structures of the enzymatic reaction products derived from 2’-fucosyllactose and 
3’-sialyllactose. (A) Reaction product derived from 2’-fucosyllactose; (B) Reaction product 
derived from 3’-sialyllactose. 
 
The P. damselae 2,6-sialyltransferase is less specific, which may allow various sialylated glycans 
to be prepared, as described above. Furthermore, it has been revealed that the 2,6-sialyltransferase 
uses both Gal1,3GlcNAc and Gal1,6GlcNAc as acceptor substrates and gives the corresponding 
(A)  (B) Mar. Drugs 2010, 8  
 
 
2786 
enzymatic reaction products, respectively [50]. These results indicate that this 2,6-sialyltransferase is 
not sensitive to the nature of the second sugar from the non-reducing terminus and to the linkage 
between the terminal two sugars. The structures of the reaction products derived from Gal1,3GlcNAc 
and Gal1,6GlcNAc are described in Figure 3. 
Figure 3. Structures of the enzymatic reaction products derived from Gal1,3GlcNAc and 
Gal1,6GlcNAc.  (A)  Reaction  product  derived  from  Gal1,3GlcNAc;  (B)  Reaction 
product derived from Gal1,6GlcNAc. 
 
It has been also revealed that the 2,6-sialyltransferase has unique donor substrate specificity. The 
sialyltransferase recognizes CMP-Neu5Ac, CMP-KDN as donor substrates and many CMP-sialic acid 
derivatives with the non-natural modification of an azido or acetylene group at positions C5, C7, C8, 
and/or C9 [51,52].  
4.2. An 2,6-sialyltransferase produced by Photobacterium sp. JT-ISH-224 
Except 2,6-sialyltransferase produced by P. damselae JT0160, three additional genes encoding the 
marine bacterial 2,6-sialyltransferase have been cloned from Photobacterium sp. JT-ISH-224 [37], 
P. leiognathi  JT-SHIZ-145  [35]  and  P.  leiognathi  JT-SHIZ-119  [36].  These  genes  have  all  been 
expressed as recombinant active form enzymes in an E. coli protein expression system. Among them, 
2,6-sialyltransferase  cloned from  Photobacterium sp.  JT-ISH-224 has been shown to  display the 
highest  specific  activity.  A  homology  search  shows  that  the  amino  acid  sequence  of  the  
2,6-sialyltransferase  from  JT-ISH-224  has  54%  identity  to  2,6-sialyltransferase  cloned  from 
P. damselae  JT0160.  The  enzymatic  property  of  the  2,6-sialyltransferase  cloned  from 
Photobacterium  sp.  JT-ISH-224  is  similar  to  that  of  the  2,6-sialyltransferase  cloned  from  
P.  damselae  JT0160.  To  date,  it  has  been  revealed  that  the  2,6-sialyltransferase  cloned  from  
JT-ISH-224 can transfer Neu5Ac to both O-6 and O-6’ hydroxyl groups of lactose simultaneously and 
gives 6,6’-disialyllactose, and transfers KDO (2-keto-3-deoxyoctonate) to the O-6’ hydroxyl group of 
lactose and gives KDO-lactose [53]. The structures of the reaction products described here are shown 
in Figure 4. 
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Figure 4. Structures of enzymatic reaction products produced by the 2,6-sialyltransferase 
cloned from JT-ISH-224. (A) 6,6’-sisialyllactose; (B) KDO-lactose. 
 
4.3. An 2,3-sialyltransferase produced by P. phosphoreum JT-ISH-467 
To date, three genes encoding the marine bacterial 2,3-sialyltransferase have been cloned from 
Photobacterium sp. JT-ISH-224 [37], P. phosphoreum JT-ISH-467 [34] and Vibrio sp. JT-FAJ-16 [38] 
and all these genes have been expressed as recombinant active form enzymes in an E. coli protein 
expression system. During the course of 3’-sialyllactose production using 2,3-sialyltransferase cloned 
from Photobacterium sp. JT-ISH-224, it has been revealed that the 2,3-sialyltransferase can transfer 
Neu5Ac to both O-2 and O-3’ hydroxyl groups of lactose simultaneously, giving 2,3’-disialyllactose as 
an enzymatic reaction product [54]. By NMR spectroscopy analysis, it has been confirmed that the 
reaction  product  contain  only  -form.  The  relative  configuration  between  C-1  to  C-3  of  the  
-glucopyranose  residue  is  superimposable  with  that  between  C-4  to  C-2  of  galactopyranose. 
Therefore, it is expected that the enzyme recognizes the -glucopyranose residue as acceptor substrate 
and transfers Neu5Ac to O-2 hydroxyl group of the -glucopyranose. In addition, it has been also 
demonstrated that the 2,3-sialyltransferase can transfer Neu5Ac to the -anomeric hydroxyl groups 
of mannose and gives the corresponding reaction product [50]. In this case, the stereochemistry of  
-mannose residue from C-2 to O-5 in the pyranose ring is superimposable on that from C-4 to C-2 of 
galactopyranose, except for the difference between the C-2 carbon atom in the Gal and O-5 oxygen 
atom  in  the Man  [50]. Thus,  it is  strongly  expected  that  the  2,3-sialyltransferase  recognizes  the 
acceptor substrate mainly through the stereochemical structure of the C-4 to C-3 of Gal [50]. The 
structures of the reaction products produced by the enzyme are shown in Figure 5. 
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Figure 5. Structures of enzymatic reaction products produced by the 2,3-sialyltransferase 
cloned  from  JT-ISH-224.  (A)  Enzymatic  reaction  product  derived  from  lactose;  
(B) Enzymatic reaction product derived from mannose. 
 
Very recently, it has been also reported that this 2,3-sialyltransferase can catalyze the transfer of 
Neu5Ac  residue  to  inositols,  non-carbohydrates,  as  well  as  to  carbohydrates  with  a  diol  structure 
corresponding to the C-3 and C-4 of the galactopyranose moiety. As described, the 2,3-sialyltransferase 
does  recognizes  both  epi-inositol  and  1D-chiro-inositol  as  acceptor  substrates,  and  gives  the 
corresponding reaction products [55]. The structures of the reaction products derived from epi-inositol 
and 1D-chiro-inositol are described in Figure 6.  
Figure 6.  Structures  of  the  enzymatic  reaction  products  derived  from  epi-inositol  and 
1D-chiro-inositol. (A) Reaction product derived from  epi-inositol; (B) Reaction product 
derived from 1D-chiro-inositol. 
 
5. Application of Sialyltransferases 
5.1. Production of sialyloligosaccharides 
A  remarkable  oligosaccharide  production  method  has  been  reported  using  a  single  growing 
metabolically engineered bacterium [56]. In this method, oligosaccharides are produced in a bacterium 
that overexpresses the recombinant glycosyltransferase genes and that maintains the pool level of the 
sugar  nucleotides  by  its  enzymatic  cellular  machinery  [57,58].  To  date,  it  has  been  reported  that 
several  oligosaccharides,  such  as  lacto-N-neotetraose,  lacto-N-neoheaxose,  and  sialyllactose,  are 
efficiently  produced  by  this  method  using  bacterial  glycosyltransferases,  such  as  
1,3-N-acetylglucosaminyltransferase,  1,4-galactosyltransferase  and  2,3-sialyltransferase  from 
N. meningitidis, 1,2-fucosyltransferase from Helicobacter pylori, etc.[56–58]. Very recently, it has 
been  also  reported  that  more  than  25  g/L  of  both  6’-sialyllactose  and  3’-sialyllactose  have  been 
(A)  (B) 
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produced by a high-density cell culture of E. coli strains overexpressing bacterial sialyltransferases of 
2,6-sialyltransferase  from  Photobacterium  sp.  and  2,3-sialyltransferase  from  N.  meningitidis, 
respectively [53,59]. In the case of the sialyllactose production system using the transformed bacterium 
by  Photobacterium  sp.  JT-ISH-224  2,6-sialyltransferase  gene,  formation  of  KDO-lactose  and 
6,6’-disialyllactose has been observed as well as 6’-sialyllactose production [53]. On the other hand, 
no formation of by-product has been observed in case of sialyllactose production system using the 
transformed bacterium by the N. meningitidis 2,3-sialyltransferase gene. These results indicate that 
the 6’-sialyllactose production system  with  marine bacterial  sialyltransferase  has  the possibility  to 
produce various kinds of sialylated carbohydrate chains, but examination of the culture conditions are 
necessary to efficiently produce the compounds aimed for [53]. 
5.2. Application of sialyloligosaccharides 
As  described  above,  influenza  A  and  B  viruses  infect  host  cells  through  the  binding  of  viral 
hemagglutinins  to  sialylglycoproteins  or  sialylglycolipids  of  the  receptors  on  the  host  cell 
surface [7,14–18]. These influenza viruses recognize both sialic acid in the receptor on the cell surface 
and  carbohydrate  chain  structures  on  the  cell  surface  including  Neu5Ac2-3(6)Gal1-3GlcNAc 
(sialyl-lacto series Type I) or Neu5Ac2-3(6)Gal1-4GlcNAc (sialyl-lacto series Type II). Therefore, 
molecules with the carbohydrate chain structures described above are thought to be potential inhibitors 
of infection by influenza virus or to be materials for influenza virus adsorption [60]. In addition, the 
ability  of  influenza  viruses  to  recognize  sialyloligosaccharides  is  known  to  be  enhanced  by  the 
clustering of sialyloligosaccharides on macromolecules [61]. Thus, a variety of glycopolymers with 
multivalent sialyloligosaccharides that target influenza viral hemagglutinines have been synthesized 
for  developing  influenza  virus  inhibitors  or  adsorption  materials  [60].  Up  to  present,  various 
glycopolymers  carrying  sialyloligosaccharides  have  been  produced  using  polyacrylamide, 
-polyglutamic  acid,  polystyrene,  chitosan  and  dendrimers  as  the  polymer  backbone,  and  their 
inhibition of influenza virus infection has also been demonstrated [60–68].  
Recently, it has been clearly demonstrated that sialyllactose (Neu5Ac2-3(6)Gal1-4Glc), Neu5Ac 
and N-acetylmannosamine could be candidates for prophylactic drugs to distal myopathy with rimmed 
vacuoles (DMRV)-hereditary inclusion body myopathy (hIBM), which is a moderately progressive 
autosomal recessive myopathy [69]. The disease gene underlying DMRV-hIBM has been predicted to 
be GNE, encoding UDP-N-acetylglucosamine-2-epimerase and N-acetylmannosamine kinase [70,71]. 
These enzymes are essential for sialic acid biosynthesis. Thus, the patients who have this disease show 
hyposialylation  in  various  organs  [72].  A  prophylactic  treatment  with  sialyllactose,  Neu5Ac  and  
N-acetylmannosamine was tested to confirm effectiveness in a mouse model of DMRV-hIBM. Oral 
treatment with the sialic acid metabolites described above completely precluded the development of 
the myopathic phenotype in the model mice [72]. Therefore, it is strongly expected that DMRV-hIBM 
in humans can potentially be treated by oral addition of sialic acid metabolites, such as sialyllactose, 
Neu5Ac and N-acetylmannosamine, and their derivatives. 
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